Persistent Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-01-04
Clinical Trial Update: Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial of brivanib alaninate in persistent or recurrent cervical cancer has completed with results posted.